Safety of Reduced Infliximab Infusion Time
NCT05340764
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
96
Enrollment
OTHER
Sponsor class
Conditions
Inflammatory Bowel Diseases
Interventions
DRUG:
Infliximab
Sponsor
Washington University School of Medicine